Federal KCPA Introduced in Congress

FDA “POCKET BAN” AUTHORITY

STATEMENT ON THE AMERICAN MEDICAL ASSOCIATION

Consumer Advisory on FDA’s Failure to Properly Regulate Kratom that Result in Product Liability Lawsuits

AKA Media Release on Import Alert Nov 14 2023

An Open Letter to the KDA Group

The American Kratom Association Issues Consumer Guidelines for Purchasing Kratom Products

Consumer Guidelines for Kratom Use

The American Kratom Association Supports Indonesian Government Request to the U.S. FDA to Lift the Kratom Import Alert

Dr. Moeldoko-Proposal to Lift Import Alert on Kratom from Indonesia

AKA letter to General TNI (Ret.) Dr. Moeldoko

AKA Response to Tampa Bay Times

Guidelines for Postmortem Investigation

Tampa Bay Times Retraction

AN OPEN LETTER TO TAMPA BAY TIMES EDITOR MARK KATCHES

City of Newport Beach CA Ban Response

Effects of kratom on driving

Dose-Finding Study of Kratom Alkaloids

NMS Labs Postmortem Challenges

Statement on the science of kratom products and their US regulation

CONSUMER WARNING ON ENHANCED 7-OH PRODUCTS

VENDOR ADVISORY ON ENHANCED 7-OH PRODUCTS

PROPOSED FY 25 REPORT LANGUAGE

AKA Response to New Georgia Kratom Law

Commentary: Mistaken Identity

OFFICIAL STATEMENT FROM CHAIRMAN OF THE AMERICAN KRATOM ASSOCIATION

Rhode Island Governor will Veto KCPA

AKA CALLS ON THE FDA TO BE FULLY TRANSPARENT AND ACCOUNTABLE IN THEIR SAFETY ALERT ON KRATOM PRODUCTS

FDA WITHDRAWAL OF DEEPLY FLAWED RISK/SAFETY DATA COLLECTION AND STUDY ON PSYCHEDELIC AND KRATOM USE

Letter to FDA Commissioner Califf

Response to False Allegations from the Global Kratom Coalition (GKC)

Response to Baseless Lawsuit Filed by JW Ross of Botanic Tonics

AKA Applauds New Jersey State Board of Medical Examiners Kratom Protection Act Endorsement

Listing of 7OH Products Improperly Marketed As Kratom